SNHG1, interacting with SND1, contributes to sorafenib resistance of liver cancer cells by increasing m6A‐mediated SLC7A11 expression and promoting aerobic glycolysis
出版年份 2023 全文链接
标题
SNHG1, interacting with SND1, contributes to sorafenib resistance of liver cancer cells by increasing m6A‐mediated SLC7A11 expression and promoting aerobic glycolysis
作者
关键词
-
出版物
ENVIRONMENTAL TOXICOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2023-11-06
DOI
10.1002/tox.24014
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma
- (2022) Wenwei Liao et al. INTERNATIONAL JOURNAL OF CANCER
- Ubiquitination regulation of aerobic glycolysis in cancer
- (2022) Yao Xie et al. LIFE SCIENCES
- Mitochondrion-Localized SND1 Promotes Mitophagy and Liver Cancer Progression Through PGAM5
- (2022) Shiwei Liang et al. Frontiers in Oncology
- Long non‐coding RNA SNHG1 activates glycolysis to promote hepatocellular cancer progression through the miR‐326/PKM2 axis
- (2022) Yue Wang et al. JOURNAL OF GENE MEDICINE
- Ursolic acid enhances the antitumor effects of sorafenib associated with Mcl-1-related apoptosis and SLC7A11-dependent ferroptosis in human cancer
- (2022) Han Li et al. PHARMACOLOGICAL RESEARCH
- SOCS2-enhanced ubiquitination of SLC7A11 promotes ferroptosis and radiosensitization in hepatocellular carcinoma
- (2022) Qianping Chen et al. CELL DEATH AND DIFFERENTIATION
- Heterogeneity, inherent and acquired drug resistance in patient-derived organoid models of primary liver cancer
- (2022) Linfeng Xian et al. CELLULAR ONCOLOGY
- Construction and Characterization of n6-Methyladenosine-Related lncRNA Prognostic Signature and Immune Cell Infiltration in Kidney Renal Clear Cell Carcinoma
- (2022) Zerong Chen et al. Journal of Oncology
- LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis
- (2022) Jiewei Xu et al. JOURNAL OF CHEMOTHERAPY
- Upregulation of lncRNA NIFK-AS1 in hepatocellular carcinoma by m6A methylation promotes disease progression and sorafenib resistance
- (2021) Yi-tian Chen et al. Human Cell
- Treatment for liver cancer: From sorafenib to natural products
- (2021) Shuli Man et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Comprehensive Pan-Cancer Analysis of the Prognostic and Immunological Roles of the METTL3/lncRNA-SNHG1/miRNA-140-3p/UBE2C Axis
- (2021) Xiulin Jiang et al. Frontiers in Cell and Developmental Biology
- SP1-induced lncRNA DUBR promotes stemness and oxaliplatin resistance of hepatocellular carcinoma via E2F1-CIP2A feedback
- (2021) S Liu et al. CANCER LETTERS
- Targeting Strategies for Tissue-Specific Drug Delivery
- (2020) Zongmin Zhao et al. CELL
- Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
- (2020) Jiao Feng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells
- (2019) Weidong Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- SND1 acts as an anti-apoptotic factor via regulating the expression of lncRNA UCA1 in hepatocellular carcinoma
- (2018) Xiaoteng Cui et al. RNA Biology
- SND1 overexpression deregulates cholesterol homeostasis in hepatocellular carcinoma
- (2016) Hiart Navarro-Imaz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- SND1 Affects Proliferation of Hepatocellular Carcinoma Cell Line SMMC-7721 by Regulating IGFBP3 Expression
- (2014) Jie Yin et al. Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started